Scott Wilkinson Profile picture
@Sowalsky lab postdoc @NCICCR_GMB • prostate cancer researcher • @emoryuniversity @winshipatemory alum
Mar 29, 2021 16 tweets 8 min read
I’m super excited about our new paper in @EUplatinum, “Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy” in @sowalsky lab @NIH @NCIResearchCtr @PCFScience Patients diagnosed w/ aggressive, non-metastatic prostate cancer are at higher risk of recurrence after radical prostatectomy (RP). Post-op, some tumors progress to castration-resistant prostate cancer. Are there tumors that will respond to pre-surgical (neoadjuvant) therapies?